Auxilium Pharmaceuticals (AUXL) Releases Quarterly Earnings, Beats Expectations By $0.05 EPS
Auxilium Pharmaceuticals (NASDAQ:AUXL) announced its earnings results on Friday. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.05, StockRatingsNetwork.com reports. The company had revenue of $125.90 million for the quarter, compared to the consensus estimate of $111.83 million.
Auxilium Pharmaceuticals (NASDAQ:AUXL) opened at 30.84 on Friday. Auxilium Pharmaceuticals has a one year low of $13.87 and a one year high of $31.26. The stock has a 50-day moving average of $25.35 and a 200-day moving average of $20.29. The company has a market cap of $1.524 billion and a P/E ratio of 13.92.
A number of analysts have recently weighed in on AUXL shares. Analysts at Jefferies Group raised their price target on shares of Auxilium Pharmaceuticals from $30.00 to $36.00 in a research note on Thursday. On a related note, analysts at RBC Capital raised their price target on shares of Auxilium Pharmaceuticals from $28.00 to $33.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. Finally, analysts at Mizuho raised their price target on shares of Auxilium Pharmaceuticals from $30.00 to $36.00 in a research note on Monday. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $25.83.
Auxilium Pharmaceuticals, Inc is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.